Our Team

Board of Directors

Glenn Haifer

Chairman

Read More

Glenn Haifer

Chairman

Glenn Haifer has over 30 years’ experience in the healthcare sector. He has successfully established four different businesses operating in primary medical services, histopathology and cosmetic medical services, which he has exited through sales to private equity firms and to an ASX listed company.
Glenn is an experienced company director. His current directorships include Sun Doctors, a health care organisation that employs 250 staff and contracting doctors and offers special interest medical services, and access to one of the largest private histopathology laboratories in Australia.
He is a Non-executive Director of Aurora Expeditions, an expedition company and travel agency that operates in remote areas of the world including the polar regions. He was also previously a Non-executive Director of BDS Vircon, a multinational engineering services business employing over 300 staff, which was sold to a US listed public company in October 2016.
In addition to his 20 years’ experience in general management of health care service delivery, Glenn has current roles as Medical Consultant to Apotex Pharmaceuticals and is the Australasian Medical Consultant to P&O/ Princess Cruises.
Glenn is a registered Australian Specialist Medical Practitioner, and a fellow of the College of Rural and Remote Medicine. He is a member of the Australian Institute of Company Directors, and was previously a member of the American Stock Exchange in New York.

Caroline Popper

Director

Read More

Caroline Popper

Director

Caroline Popper is a US-based pathologist and business consultant, with more than 20 years’ operational experience in the international diagnostics, medical devices and drug discovery fields. After 10 years in senior management and marketing roles at Becton, Dickinson and Company, Caroline established her own consultancy company to provide strategic corporate and advisory services to businesses across the life sciences spectrum.
A qualified health economist, Caroline has served in senior managerial and advisory positions at a number of global diagnostics and medical research companies, including bioMérieux and MDS Proteomics, where she was Chief Business Officer from 2000 to 2002. As well as extensive corporate experience, Caroline enjoys a hands-on clinical perspective from her years as an attending physician at the Department of Emergency Medicine at Baltimore’s Johns Hopkins Hospital, where she completed residencies in internal medicine and pathology.
In 2003, Caroline founded Popper and Company, a strategy and M&A advisory firm focused on diagnostics, medical devices, life science tools, and wireless health applications. Her other directorships include Innovative Biosensors Inc (Chairman), nanoMR, Rarecyte and Pilgrim Software Inc.

Herman Scholtz

Director

Read More

Herman Scholtz

Director

Dr. Herman Scholtz, MD, has over 20 years of Pharmaceutical and CRO early drug development experience. Until recently he was the Global Vice President and General Manager, Clinical Pharmacology Services for Covance. During his tenure at Covance, he also served as the Chief Medical Officer and was a member of the Covance global Operating Committee and Scientific Council. Prior to joining Covance, Dr. Scholtz held several leadership positions in Early Drug Development over a 15-year career with PAREXEL International.
Dr. Scholtz qualified as a physician at the University of Pretoria, South Africa and qualified as an anesthesiologist at the University of the Free State in Bloemfontein, South Africa. He currently resides in Madison, WI (USA)

Garth Tierney

Director

Read More

Garth Tierney

Director

Garth Tierney is a South Australian based pharmacology and management professional with over 30 years’ experience in the clinical trial industry. Garth held various research and management roles within several international pharmaceutical and CRO companies before founding the Australian based CRO, Trident Clinical Research in 1997. As CEO, Garth grew Trident to become a leading Australian independent CRO with operations in three countries and 140 staff. Following acquisition of Trident by an international CRO, INC Research (now Syneos Health), Garth held the position of Senior Executive Vice President for Asia Pacific with oversight for 12 countries and over 500 staff. Garth retired from the role in 2014. Garth was also a founding partner and board member of Australia’s leading clinical trial manufacturing and logistics specialist, Pharmaceutical Packaging Professionals, which was acquired by a large international company in 2018.
Garth’s board experience spans CRO companies, an early phase clinical research facility, pharmaceutical manufacturing, advanced plastics moulding and sporting organisations.



Leadership Team

Yvonne Lungershausen

Chief Executive Officer

Read More

Yvonne Lungershausen

Chief Executive Officer

Yvonne began her career in academic “bench” research with Adelaide University and CSIRO. Yvonne then moved into clinical trials research at a dedicated Phase I unit where she was one of the first in Australia to test a new chemical entity in healthy volunteers, giving rise to what is now a strong Phase 1 sector in Australia.

Yvonne also spent time in the biotech world as Clinical Development Manager then moved into senior Contract Research Organisation (CRO) roles.

With 25+ years of clinical trial experience gained across most therapeutic areas, Yvonne brings a deep understanding of all phases of the drug development process. With a passion for exceeding client expectations, Yvonne is highly regarded within the industry for her expertise and ability to solve complex clinical trial issues.

In 2009 Yvonne Lungershausen became a Founding Member of CPR Pharma Services (CPR) as it spun out from the University of South Australia. As a key member of the CPR Senior Management Team she was responsible for the clinical operations side of the business.

Then in January 2019 CPR Pharma Services split into two separate service companies, analytical services (Agilex BioLabs) and clinical services (Avance Clinical).

Yvonne was appointed as CEO of Avance Clinical and has since rapidly built the company into Australia’s leading CRO for biotechs – attracting innovative biotech clients from USA, EU and Asia and winning awards for quality and service.

Gabriel Kremmidiotis

Chief Scientific Officer

Read More

Gabriel Kremmidiotis

Chief Scientific Officer

Gabriel has 26 years’ experience in medical research and drug development. He has devoted most of his career to the biotechnology industry, managing drug development programs from early discovery to completion of phase II proof of concept clinical trials and subsequent commercial drug licensing deals.
He has been part of the CPR Pharma Services team since 2015 managing the department of clinical operations and offering drug development advice to biotechnology companies seeking to enter clinical trials in Australia. In 2019, Gabriel was appointed Chief Scientific Officer of Avance Clinical where he currently leads the Department of Scientific and Medical affairs offering Medical Writing, Drug safety monitoring and reporting and early phase clinical drug development and regulatory advice services.
Prior to joining CPR Pharma Services, Gabriel was the Vice President Research & Development of the Australian ASX listed company Bionomics limited where over several years led teams in discovery and progression of cancer therapeutics through to completion of several phase I and Phase II clinical trials in Australia and the US.
Gabriel’s 26 years in medical research also includes appointments with the Cancer Therapeutics CRC, Flinders University of South Australia, Adelaide University, the Los Alamos National Laboratories and the Adelaide Women’s and Children’s Hospital.
With primary expertise in oncology, Gabriel has a diverse scientific background spanning the fields of Clinical Development, Drug Discovery, Cancer Biology, Molecular Genetics, Bioinformatics and Immunology. He has a PhD and a Bachelor of Science (Honours) from Flinders University and a Bachelor of Science from The University of Melbourne. He has published research findings in 29 international scientific papers and has several patent inventions on cancer genes and small molecule anti-cancer therapeutics. Gabriel is a member of the American Association for Cancer Research, the American Society of Clinical Oncology and ARCS Australia.

Ben Edwards

Chief Strategy Officer

Read More

Ben Edwards

Chief Strategy Officer

Chief Strategy Officer; working closely with the CEO to lead growth of the business and align the organisations operations with its future goals. With 24+ years of industry experience, including 19+ years within in CROs, Ben has gained a depth of knowledge that has allowed him to successfully support clients internationally and in the Asia Pacific region to gain market registration for their new pharmaceutical drug products. This includes product approvals by the US FDA, in Europe, the Japan PMDA and Chinese CFDA.

As an accomplished leader of teams with significant experience in directing large multi-function teams across all continents Ben values an action oriented work ethic, high ethical standards, personal integrity and accountability as well as the power of a ‘team first’ culture. These values have been the guiding force for delivering value to clients and ensuring patients get the treatment they need.

Stephen Birrell

Chief Commercial Officer

Read More

Stephen Birrell

Chief Commercial Officer

Chief Commercial Officer, Stephen Birrell joined Avance Clinical following a 30 year career which has spanned commercial management, financial, treasury and company secretarial roles in a variety of industry sectors, including 10+ years in the biotech industry. With 30+ years’ experience in roles that directly support high growth companies, mergers and acquisitions Mr Birrell is an asset to Avance Clinical by assisting in the alignment of commercial operations and future goals. Mr Birrell holds a Bachelor of Business (Accounting) from Monash University and is a member of the Institute of Public Accountants.

Jemma Lawson

Director Clinical Operations

Read More

Jemma Lawson

Director Clinical Operations

Jemma brings to Avance Clinical in-depth experience in Clinical Operations supported by 17+ years’ experience working in the clinical research and biotechnology industries, including 12+ years dedicated to various roles in Contract Research Organisations (CROs). Her comprehensive knowledge draws from working with both small Australian-based CROs and large multinational (including Top 5) CROs, with a particular focus on early phase Healthy Volunteer and Oncology clinical development.

Highly developed people management expertise, demonstrated accountability for a project delivery, thorough clinical project financial management experience, and an innate love for process improvement and development/implementation, provide her with a solid foundation to deliver on the continued growth and development of the Avance Clinical Operations department.

Glynn Morrish

Director Biometrics

Read More

Glynn Morrish

Director Biometrics

Glynn Morrish is a Senior Pharmacokineticist / Biostatistician and is responsible for the analysis and communication of clinical trial data and results to internal and external stakeholders. Glynn has over 15 years’ experience in clinical research and data analysis in both industry and academic settings. He has a passion for the science and business aspects of quantitative drug development, which is demonstrated by his contribution to the development of over 100 pharmaceutical products, the leading of statistical analysis teams, the conduct of non-for-profit and commercial pharmacokinetic data analysis courses, his peer-reviewed publication track record, and the supervision of post-graduate research students. Glynn’s current focus is on providing rational, informed and intelligent analysis and consulting services to small-to-medium sized clinical development organisations, assisting them to maximise study outcomes, product understanding and company value.

Sandrien Louwaars

Director Business Development Operations

Read More

Sandrien Louwaars

Director Business Development Operations

With expertise gained working for leading global CROs in Europe, Sandrien is an experienced Senior Clinical Data Specialist with expertise in Oracle Clinical™, Clintrial, Medrio, and SAS®.
With a keen eye for detail, Sandrien brings rigour and critical thinking to Protocol Review, Preparation of Data Management Plans, Case Report Form design and programming of Database and Edit Checks.

Priyanka Chamoli

Director Quality Assurance

Read More

Priyanka Chamoli

Director Quality Assurance

Priyanka has extensive experience in Clinical Research and holds a Post-graduate degree in Clinical Research.
Priyanka has worked in Pharma, Multinational and small to mid-sized CROs during her career.
She has extensive experience auditing Investigator sites and vendors across multiple regions including Asia, Africa, Australia, Europe and the USA covering many therapeutic areas.
At Avance Clinical Priyanka is responsible for quality systems and auditing for Clinical Operations, Data Management, Medical Writing and Statistics.

Lisa Eglinton

Director Compliance & Training

Read More

Lisa Eglinton

Director Compliance & Training

Lisa Eglinton is Director Compliance and Training, responsible for driving the delivery and management of training programs and clinical compliance with internal processes and global regulations. Lisa has worked within the Contract Research Organization industry for almost 20 years, building on 10 years of experience within a pharmaceutical company and within a Phase I clinical trials unit. She has a strong background in Phase I clinical research and a wide breadth of experience across many facets of clinical research. Lisa’s strong passion for training and sharing knowledge enables her to effectively promote compliance to achieve high quality outcomes for clients.